Prosecution Insights
Last updated: October 02, 2026

Examiner: ALTER MORSCHAUSER, ALYSSA MARGO

Tech Center 3700 • Art Units: 3762 3792 3796

This examiner grants 76% of resolved cases

Analysis

Alyssa Margo Alter Morschauser is a patent examiner in Tech Center 3700 and Art Unit 3762. She has 808 resolved cases, which provides a very reliable dataset for evaluating her prosecution patterns. This high volume of resolutions indicates extensive experience in managing a large docket of patent applications.

The allowance rate for this examiner is 76.5 percent. This percentage represents the portion of applications that result in a patent grant. For practitioners, this 76.5 percent rate serves as a benchmark for the likelihood of success when navigating the examination process in Tech Center 3700.

The interview lift is 15.7 percent. This figure indicates the increase in the probability of allowance following an interview. The 15.7 percent lift suggests that verbal engagement with the examiner is an effective strategy for clarifying technical points and reaching agreement on claim scope in Art Unit 3762.

The median days to allowance is 1215. This metric provides a timeline for the expected duration of the prosecution process from filing to grant. Understanding this 1215 day median allows for better resource planning and expectation management for clients seeking patents under this examiner's supervision.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

76.5%
Allow Rate
+6.5% vs TC avg
848
Total Applications
+15.8%
Interview Lift
1214
Avg Prosecution Days
Based on 809 resolved cases, 2023–2026

Rejection Statute Breakdown

4.9%
§101 Eligibility
26.7%
§102 Novelty
37.1%
§103 Obviousness
17.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18600430 Seamlessly Embedded Heart Rate Monitor Final Rejection Apple Inc.
18904579 SYSTEM AND METHOD FOR PRESSURE MONITORING WITHIN A CATHETER SYSTEM Non-Final OA Boston Scientific Scimed, Inc.
18908610 SYSTEMS AND METHODS FOR DORSAL NERVE ROOT STIMULATION Non-Final OA Boston Scientific Neuromodulation Corporation
18682972 METHOD AND SYSTEM FOR MONITORING PATIENTS FOR SEPSIS FOLLOWING DISCHARGE Final Rejection KONINKLIJKE PHILIPS N.V.
18719225 MEDICAL SUPPORT METHOD, MEDICAL SUPPORT ROBOT DEVICE, AND COMPUTER PROGRAM Non-Final OA NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
18694140 MEDICAL DEVICE SYSTEM INCLUDING A PROGRAMMABLE IMPLANTABLE MEDICAL DEVICE SUCH AS A NEUROSTIMULATOR AND METHOD FOR OPERATING SAME Final Rejection BIOTRONIK SE & Co. KG
18576237 PERSONALIZED THERAPY NEUROSTIMULATION SYSTEMS Final Rejection Cala Health, Inc.
18216258 ADHESIVE LAYER WITH PROTECTIVE BORDER FOR USE IN A TUMOR TREATING FIELDS TRANSDUCER Final Rejection Novocure GmbH
19043657 SYSTEMS AND METHODS FOR THE TREATMENT OF PAIN THROUGH NEURAL FIBER STIMULATION Non-Final OA SPR Therapeutics, Inc.
19002021 SYSTEMS AND METHODS FOR THE TREATMENT OF PAIN THROUGH NEURAL FIBER STIMULATION Non-Final OA SPR Therapeutics, Inc.
18820820 SYSTEMS AND METHODS TO PLACE ONE OR MORE LEADS IN TISSUE TO ELECTRICALLY STIMULATE NERVES TO TREAT PAIN Non-Final OA SPR THERAPEUTICS, INC.
18820458 SYSTEMS AND METHODS FOR THE TREATMENT OF PAIN THROUGH NEURAL FIBER STIMULATION Non-Final OA SPR Therapeutics, Inc.
18965728 SYSTEM FOR PROVIDING NEUROMODULATION, ESPECIALLY NEUROSTIMULATION Non-Final OA ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
18352846 SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION Final Rejection Nevro Corp.
18656973 CATEGORIZATION AND ANALYSIS OF LOW SIGNAL QUALITY IN ECG DATA Final Rejection Boston Scientific Cardiac Diagnostics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month